The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial
Jeffrey How, Amir A. Jazaeri, Shannon N. Westin, Anil K. Sood, Lois M. Ramondetta, Mingxuan Xu, Abdulrahman Abonofal, Daniel D. Karp, Vivek Subbiah, Bettzy Stephen, Jordi Rodón, Fei Yang, Aung Naing
Topics & Concepts
PembrolizumabOvaryMedicineClinical trialOncologyInternal medicineImmunotherapyCancerOvarian cancer diagnosis and treatmentCancer Immunotherapy and BiomarkersCytokine Signaling Pathways and Interactions